Active Clinical Trials taking place in Australia

We have generated a Free Sample of Synthetic, realistic, and 100% customized clinical trial data for the active clinical trials in Australia.

Synthetic Health Data allows companies to speed up and improve software development, helping them to test and validate systems during the whole development process.

The data we provide has different uses:

Below you will find all active clinical trials in Australia and the downloadable Synthetic Health Data we created for each active clinical trial. Feel free to use the search menu if you want to search any specific NCTID, title or sponsor.

Official Title Sponsor
NCT04215809 Study of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents for CLL/SLL Ascentage Pharma Group Inc.
NCT04205227 ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors ENB Therapeutics, Inc
NCT04117854 Spinal Cord Injury in the Pediatric Population - an International Multicenter Study Sunnaas Rehabilitation Hospital
NCT04094610 A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations Turning Point Therapeutics, Inc.
NCT04052971 To Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of ABN401 in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer Harboring c-MET Dysregulation Abion Inc
NCT04046224 Dose-Ranging Study of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease Sangamo Therapeutics
NCT04029363 Feasibility Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients With Moderate-severe or Severe Mitral Regurgitation and at High Surgical Risk HighLife SAS
NCT04024111 Social Groups for Australian Children on the Autism Spectrum Curtin University
NCT03980171 Study of Lenalidomide, Venetoclax and Obinutuzumab in Patients With Treatment-Naïve Follicular Lymphoma Peter MacCallum Cancer Centre, Australia
NCT03912909 Effects of Sodium-glucose Co-transporter-2( SGLT-2 ) Inhibition on Sympathetic Nervous System Activity in Humans Royal Perth Hospital
NCT03911505 ZIP Study-OL Study of Safety, PK, Efficacy, PD, Immunogenicity of ATB200/AT2221 in Pediatrics Aged 0 to < 18 y.o. w/LOPD Amicus Therapeutics
NCT03906669 A Window of Opportunity Study of Pre-operative Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Breast Hormone Receptor Positive (HR+) Human Epidermal Receptor 2 Negative (HER2-) Breast Cancer. St Vincent's Hospital
NCT03900442 Phase 1 Study of PTX-100 in Patients With Advanced Malignancies With PTCL Expansion Cohort Prescient Therapeutics, Ltd.
NCT03816397 Adalimumab in JIA-associated Uveitis Stopping Trial Nisha Acharya
NCT03788811 ERG Components in Schizophrenia and Bipolar Disorder Type I diaMentis Inc.
NCT03734640 Optimal Post Tpa-Iv Monitoring in Ischemic Stroke Craig Anderson
NCT03717623 Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants Melbourne Health
NCT03563053 Open-label, Long-term, Extension Treatment Using Intra-Erythrocyte Dexamethasone Sodium Phosphate in Patients With Ataxia Telangiectasia Who Participated in the IEDAT-02-2015 Study Erydel
NCT03537482 APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies Ascentage Pharma Group Inc.
NCT03382340 IMX-110 in Patients With Advanced Solid Tumors Immix Biopharma Australia Pty Ltd
NCT03148600 Rehabilitation After Ileo-anal Pouch Surgery St Vincent's Hospital Melbourne
NCT03050476 Preventing Systemic Inflammation After Cardiac Surgery With Alkaline Phosphatase Alloksys Life Sciences B.V.
NCT02984566 Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM) University of Sydney
NCT02629952 Metabolic Benefits of Drinking Blueberry Tea in Type 2 Diabetes Menzies Institute for Medical Research
NCT02065999 Surveillance for Antiviral Resistant Variants in Chronic Hepatitis C Patients Kirby Institute
NCT05727189 A Study of the Safety, Tolerability and Pharmacokinetics of Idazoxan in Healthy Participants Terran Biosciences Australia Pty Ltd
NCT05725291 AMT-116 in Patients With Selected Advanced Solid Tumors Multitude Therapeutics Inc.
NCT05698277 Automated Fetal Cardiac Function in Babies Affected by Heart Diseases Anna Erenbourg
NCT05666700 CAR-T Cell Therapy in RelApsed/Refractory Myeloma With ExtrameduLlary Disease - an in Vivo Imaging and Molecular Monitoring Study Peter MacCallum Cancer Centre, Australia
NCT05614258 Study of ADG206 in Subjects With Advanced/Metastatic Solid Tumors Adagene Inc
NCT05583552 Study to Evaluate Imetelstat in Patients With High-Risk MDS or AML Failing HMA-based Therapy GCP-Service International West GmbH
NCT05568381 Sleep Disturbance in MCI: A Study of a Cognitive Behavioural Therapy Digital Intervention University of Sydney
NCT05528302 Technology Assisted Cognitive Behavioural Therapy Intervention for Anxiety in People Living With Cognitive Impairment The University of Queensland
NCT05500612 MRI Hypoxia Study for Glioblastoma Multiforme (GBM) Radiation Therapy University of Sydney
NCT05456724 A Study to Investigate the Effect of IOP-lowering With TO-O-1001 Eye Drops in Healthy Subjects and in Patients With Open-Angle Glaucoma or Ocular Hypertension Theratocular Biotek Co.
NCT05441930 A Study of Levofloxacin Ocular Implant in Patients Undergoing Routine Bilateral Cataract Surgery PolyActiva Pty Ltd
NCT05414747 Clinical Investigation of the Safety and Effectiveness of the ABV-1701 Ocular Endotamponade (OE) BioFirst Corporation
NCT05169177 Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy: An Observational Feasibility Study University of Sydney
NCT05152901 Study of Inhaled Epinephrine and Intramuscular Epinephrine Administered to Healthy Adults De Motu Cordis
NCT05030207 Respiratory Adaptive Computed Tomography: Feasibility Study on Real-Time Gated 4DCT for Lung Cancer Radiotherapy University of Sydney
NCT04935762 A Study of CST-103 Co-administered With CST-107 in Subjects With Parkinson's Disease Having Freezing of Gait (CLIN-012) CuraSen Therapeutics, Inc.
NCT04789096 Tucatinib Together With Pembrolizumab and Trastuzumab Breast Cancer Trials, Australia and New Zealand
NCT03810573 Evaluation of NB1 Bone Graft Following Lumbar Interbody Arthrodesis Bone Biologics Corp
NCT05629559 4D-310 in Adults With Fabry Disease and Cardiac Involvement 4D Molecular Therapeutics
NCT05614570 SSVEP Evaluation of Brain Function Headsafe MFG
NCT05490017 To Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Escalating Single and Multiple Doses of KP104 Kira Pharmacenticals (US), LLC.
NCT05426746 First-In-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALT-100 Aqualung Therapeutics Corp.
NCT05367973 Study of DARE-HRT1 Over 12 Weeks in Healthy PostMenopausal Women Daré Bioscience, Inc.
NCT05357677 To Evaluate the Efficacy and Safety of SR419 in Patients With Postherpetic Neuralgia (PHN) Shanghai SIMR Biotechnology Co., Ltd.
NCT05151601 Combined Human Milk Oligosaccharides (HMOs) and Probiotics Intervention for Children With Autism The University of Queensland
NCT05084859 A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors Biosplice Therapeutics, Inc.
NCT05041114 SWITCH II Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis Synchron Medical, Inc.
NCT05033483 Do Iron Supplements Impact the Gut Microbiome of Women of Reproductive Age? South Australian Health and Medical Research Institute
NCT05017662 A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072 Ipsen
NCT04931862 Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD) Wave Life Sciences Ltd.
NCT04914117 A Study of RC118 in Patients With Locally Advanced Unresectable/Metastatic Solid Tumours RemeGen Co., Ltd.
NCT04892524 Virtual Management of Lung Nodules Southern Adelaide Local Health Network
NCT04849273 A Study of TPX-0131, a Novel Oral ALK Tyrosine Kinase Inhibitor, in Patients With ALK+ Advanced or Metastatic NSCLC Turning Point Therapeutics, Inc.
NCT04838353 Alleviate-HF-2 Study Alleviant Medical, Inc.
NCT04778410 Study of Magrolimab Combinations in Participants With Myeloid Malignancies Gilead Sciences
NCT04774224 Baricitinib in New-onset Type 1 Diabetes St Vincent's Institute of Medical Research
NCT04739423 A Study of CST-103 Co-administered With CST-107 in Subjects With Neurodegenerative Disorders CuraSen Therapeutics, Inc.
NCT04647890 Effects of FT011 in Systemic Sclerosis Certa Therapeutics
NCT04629443 Phase I/II Trial of S64315 Plus Azacitidine in Acute Myeloid Leukaemia Institut de Recherches Internationales Servier
NCT04605978 Efficacy and Safety of S95011 in Primary Sjögren's Syndrome Patients Institut de Recherches Internationales Servier
NCT04537832 Natural History Study of Infants and Children With Developmental and Epileptic Encephalopathies Encoded Therapeutics
NCT04529928 An Initial Evaluation of the Carillon Mitral Contour System for Treatment of Atrial Function Mitral Regurgitation Cardiac Dimensions Pty Ltd
NCT04526704 Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib Daiichi Sankyo, Inc.
NCT04489368 Response Prediction to Neoadjuvant Chemoradiation in Esophageal Cancer Using Artificial Intelligence & Machine Learning Dr Kundan Singh Chufal
NCT04480463 A Study to Comparing SCD411 and Eylea® in Subjects With Wet Age-related Macular Degeneration (AMD) Sam Chun Dang Pharm. Co. Ltd.
NCT04455503 Study of Adjuvant Immunotherapy With EVX-02 and Anti-PD-1 Evaxion Biotech A/S
NCT04385277 Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL) Children's Oncology Group
NCT04383210 Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors Elevation Oncology
NCT04354818 Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA) Kirby Institute
NCT04323046 Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults Sabine Mueller, MD, PhD
NCT04304482 ANAVEX2-73 Study in Pediatric Patients With Rett Syndrome Anavex Life Sciences Corp.
NCT04300244 Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma Åslaug Helland
NCT04262336 Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment Decibel Therapeutics
NCT04234061 Clinical Trial to Assess The Efficacy and Safety of the Combination of Tisagenlecleucel And Ibrutinib in Mantle Cell Lymphoma Peter MacCallum Cancer Centre, Australia
NCT04201262 An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD Alexion Pharmaceuticals
NCT04186637 An Open-label Study of ALPN-202 in Subjects With Advanced Malignancies Alpine Immune Sciences, Inc.
NCT04154943 Study of Cemiplimab in Patients With Type of Skin Cancer Stage II to IV Cutaneous Squamous Cell Carcinoma Regeneron Pharmaceuticals
NCT04042025 Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi Novartis Gene Therapies
NCT03897205 An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients Hansa Biopharma AB
NCT03894020 GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD) Gyroscope Therapeutics Limited
NCT03763682 BilatEral Hypoglossal Nerve StimulaTion for TreatmEnt of ObstRuctive SLEEP Apnoea With and Without Complete Concentric Collapse Nyxoah S.A.
NCT03755128 A Study to Characterize the Clinical Course of Pregnant Women and Children at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn Momenta Pharmaceuticals, Inc.
NCT03750786 A Study to Compare the Efficacy of Arfolitixorin Versus Leucovorin in Combination With 5 Fluorouracil, Oxaliplatin, and Bevacizumab in Patients With Advanced Colorectal Cancer Isofol Medical AB
NCT03720431 TTAC-0001 and Pembrolizumab Phase Ib Combination Trial in Metastatic Triple-negative Breast Cancer PharmAbcine
NCT03710876 Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma Trizell Ltd
NCT03616470 Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid Leukemia GlycoMimetics Incorporated
NCT03610061 A Trial of Radiotherapy and Durvalumab in DLBCL and FL Austin Health
NCT03608670 Extravascular ICD Pilot Study Medtronic Cardiac Rhythm and Heart Failure
NCT03535740 A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib Ariad Pharmaceuticals
NCT03430401 Computer-based Cognitive Rehabilitation Program for Healthy Older Adults, Older People With Mild Cognitive Impairment and Mild Dementia University of Western Sydney
NCT03299660 Avelumab With Chemoradiation in Locally Advanced Rectal Cancer Peter MacCallum Cancer Centre, Australia
NCT03277196 A Study to Evaluate the Safety of Long-term Ivacaftor Treatment in Subjects With Cystic Fibrosis Who Are Less Than 24 Months of Age at Treatment Initiation and Have an Approved Ivacaftor-Responsive Mutation Vertex Pharmaceuticals Incorporated
NCT03245021 Nivolumab Plus Rituximab in First-line Follicular Lymphoma gr 1-3A Dr. Eliza Hawkes
NCT03227042 A Prospective Natural History Study of Mucopolysaccharidosis Type IIIB (MPS IIIB) Allievex Corporation
NCT03177044 Behavioural Treatment for Functional Bowel Symptoms in Inflammatory Bowel Disease St Vincent's Hospital Melbourne
NCT03148327 Astra Zeneca (Immuno Stereotactic Ablative Body Radiotherapy) ISABR Study: Randomized Phase I/II Study of Stereotactic Body Radiotherapy Jonsson Comprehensive Cancer Center
NCT03146468 Nivolumab for Relapsed or Residual Haematological Malignancies After Allogeneic Stem Cell Transplantation Melbourne Health
NCT03136809 ALS Treatment Extension Study Collaborative Medicinal Development Pty Limited
NCT03113942 Study of Pomalidomide in Anal Cancer Precursors Kirby Institute
NCT03005327 A Dose Determination and Safety Study of X4P-001 (Mavorixafor) in Participants With Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) Syndrome X4 Pharmaceuticals
NCT02922036 Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients EBR Systems, Inc.
NCT02881203 Breast Radiotherapy Audio Visual Enhancement for Sparing the Heart University of Sydney
NCT02875548 Tazemetostat Rollover Study (TRuST): An Open-Label, Rollover Study Epizyme, Inc.
NCT02858921 Neoadjuvant Dabrafenib, Trametinib and/or Pembrolizumab in BRAF Mutant Resectable Stage III Melanoma Melanoma Institute Australia
NCT02807181 SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma Sirtex Medical
NCT02708875 Microvascular Insulin Resistance and Mixed Meal Challenge Menzies Institute for Medical Research
NCT02662062 Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer Australian and New Zealand Urogenital and Prostate Cancer Trials Group
NCT02613819 Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney Trans Tasman Radiation Oncology Group
NCT02610660 Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension Association for Pediatric Pulmonary Hypertension
NCT02302872 Treatment of Heart Failure and Associated Functional Mitral Valve Regurgitation Mvrx, Inc.
NCT02030964 N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/Topotecan New Approaches to Neuroblastoma Therapy Consortium
NCT02004691 Efficacy, Safety, Pharmacodynamic, and Pharmacokinetics Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency Genzyme, a Sanofi Company
NCT01972347 Neoadjuvant Dabrafenib + Trametinib for AJCC Stage IIIB-C BRAF V600 Mutation Positive Melanoma Melanoma Institute Australia
NCT01887938 An Efficacy and Safety Study of HGT-1110 in Participants With Metachromatic Leukodystrophy Shire
NCT01796171 A Phase I/II Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma Nordic Nanovector
NCT01100892 Cystic Fibrosis - Insulin Deficiency, Early Action Sydney Children's Hospitals Network
NCT00975520 Neurotropic Melanoma of the Head and Neck Melanoma and Skin Cancer Trials Limited
NCT00653068 Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System Children's Oncology Group
NCT00319579 A Prospective Study of Living Kidney Donation Amit Garg
NCT05517564 First-in-Human Study of GM-60106 in Healthy Adults and Otherwise Healthy Adults With an Increased Body Mass Index and Markers of Non-Alcoholic Fatty Liver Disease JD Bioscience Inc.
NCT05004129 Safety and Efficacy of Tideglusib in Congenital Myotonic Dystrophy AMO Pharma Limited
NCT04774185 Hearing Aid Transmitter Performance Study - SRF-366 Sonova AG
NCT03882671 Development of a Minimally Invasive Seizure Gauge Seer Medical Pty Ltd
NCT03229200 Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib. Pharmacyclics Switzerland GmbH
NCT05710341 Nitrate INFORMER Water Study Edith Cowan University
NCT05646836 A Study to Evaluate the Safety, Pharmacokinetics, and Activity of XmAb24306 in Combination With Cevostamab in Participants With Relapsed/Refractory Multiple Myeloma Genentech, Inc.
NCT05638347 A Trial of HRS-7085 Tablet in Healthy Participants With and Without Food Effect. Atridia Pty Ltd.
NCT05636514 Combined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS Clinical Hub for Interventional Research (CHOIR)
NCT05635084 A First-in-human Study of YN001 in Healthy Volunteers Beijing Inno Medicine Co., Ltd.
NCT05621317 A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy Aravax Pty Ltd
NCT05610176 BIO|CONCEPT.Amvia Study Biotronik Australia Pty Ltd.
NCT05607498 First in Human Study of EMB-07 in Locally Advanced/Metastatic Solid Tumors EpimAb Biotherapeutics (Suzhou)Co., Ltd.
NCT05605951 Acute Optic Neuritis Network: an International Study That Invesitages Subjects With a First-ever Episode of Acute Inflammation of the Optic Nerve Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul
NCT05587283 Safety, Tolerability, and Acceptability Study of Intravaginal Administration of LABTHERA-001 Capsules in Healthy Women AtoGen Co. Ltd
NCT05570591 Subthreshold Nanosecond Laser for Non-resolving Central Serous Chorioretinopathy Nova Eye Medical Pty Ltd.
NCT05549219 12-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Adults With PMM2-CDG Glycomine, Inc.
NCT05544552 Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations Tyra Biosciences, Inc
NCT05511922 PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 Trial KalVista Pharmaceuticals, Ltd.
NCT05501574 An Open Label Trial Evaluating Tacrolimus Inhalation Powder in Adult Lung Transplant Recipients TFF Pharmaceuticals, Inc.
NCT05494918 First-In-Human Study in Subjects With Advanced or Metastatic Solid Malignant Tumors Alphamab (Australia) Co Pty Ltd.
NCT05476770 Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies Therapeutic Advances in Childhood Leukemia Consortium
NCT05475925 A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas Dren Bio
NCT05473533 Study of Single and Multiple Doses of PRS-220 Administered by Oral Inhalation in Healthy Subjects Pieris Australia Pty Ltd
NCT05462223 Alucent Vessel Restoration System for AVF Alucent Biomedical
NCT05456269 A Study of Bisantrene Combined With Cytarabine or With Decitabine for Adult Subjects With Extramedullary AML and MDS Race Oncology Ltd
NCT05454020 A Study of Topical XG004 in Participants With Osteoarthritis of the Knee Xgene Pharmaceutical Pty Ltd
NCT05420077 Safety and Immunogenicity of RVM-V001 in Healthy Individuals Previously Vaccinated With BNT162b2 and mRNA-1273 RVAC Medicines (US), Inc.
NCT05411133 Treatment of ARB202 Advanced Gastrointestinal Cancer Patients Arbele Pty Ltd
NCT05408572 Study of SON-1010 (IL12-FHAB) in Healthy Adults Sonnet BioTherapeutics
NCT05399654 A Dose Escalation and Expansion Study of TAC-001 in Patients With Select Advanced or Metastatic Solid Tumors Tallac Therapeutics
NCT05397041 A 3-Part Study to Evaluate the Safety, Tolerability, PK, and Food Effect of BMB-101 in Healthy Volunteers Bright Minds Biosciences Pty Ltd
NCT05385991 Booster Dose Study to Assess the Safety and Immunogenicity of ACM-001 Administered Intramuscularly or Intranasally. ACM Biolabs
NCT05374941 StimAire Sleep Study StimAire Australia Pty Ltd
NCT05360394 A Prospective, Randomized Controlled Trial of Stent Graft and Drug Coated Balloon Treatment for Recurrent Cephalic Arch Stenosis in Dysfunctional Arteriovenous-venous Fistula Singapore General Hospital
NCT05355298 AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer Amplia Therapeutics Limited
NCT05352893 Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With GPP AnaptysBio, Inc.
NCT05348694 OsteoPreP: Food Supplements for Postmenopausal Bone Health Australian Catholic University
NCT05344157 A First-in-Human Study of XSTEM-OA in Patients With Knee Osteoarthritis Xindu Pty Ltd
NCT05331300 A Study to Evaluate the Safety and Pharmacokinetic Properties of LASN01 in Healthy Subjects and in Patients With Pulmonary Fibrosis Lassen Therapeutics 1 PTY LTD
NCT05327803 Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease AN2 Therapeutics, Inc
NCT05325034 Guideline Oriented Approach To Lipid Lowering In Asia-Pacific Stephen Nicholls
NCT05311176 A Study of IMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HER2/Neu Over-Expressing Gastric Cancer (nextHERIZON) Imugene Limited
NCT05308953 A Phase I Safety Study of NVG-291 in Healthy Adults NervGen Pharma
NCT05307783 EmboCube Gelatin Embolization to Control Bleeding or Hemorrhaging Merit Medical Systems, Inc.
NCT05298306 A Two-part Proof-of-Concept Study Assessing the Safety and Efficacy of LAT8881 in Lumbar Radicular Pain Lateral Pharma Pty Ltd
NCT05293184 The Global Angelman Syndrome Registry Foundation for Angelman Syndrome Therapeutics, Australia
NCT05276570 Study of ARO-RAGE in Healthy Subjects and Patients With Asthma Arrowhead Pharmaceuticals
NCT05272605 Safety and Immune Response of Adjuvanted SARS-CoV-2 (COVID-19) Beta Variant RBD Recombinant Protein (DoCo-Pro-RBD-1 + MF59®) and mRNA (MIPSCo-mRNA-RBD-1) Vaccines in Healthy Adults University of Melbourne
NCT05270876 Innovations in Clinical Care of CE Approved Nucleus Cochlear Implant Recipients Cochlear
NCT05269316 Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors Impact Therapeutics, Inc.
NCT05268198 SAD Study of APR002 Investigating the Safety/Tolerability, Pharmacokinetics/Pharmacodynamics in Healthy Subjects Global Health Drug Discovery Institute
NCT05267626 Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer Aulos Bioscience, Inc.
NCT05266105 A Phase 1 Study of Oral OP-1250 in Combination With Palbociclib in HR+/HER2- Breast Cancer Patients Olema Pharmaceuticals, Inc.
NCT05258773 Evaluation of the Presence of SENS-401 in the Perilymph Sensorion
NCT05253417 The CANabidiol Use for RElief of Short Term Insomnia Bod Australia
NCT05238207 A Study to Evaluate BBI-001 in Hereditary Haemochromatosis (HH) Patients and Iron Deficient Volunteers Bond Biosciences
NCT05233397 ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma Nationwide Children's Hospital
NCT05230758 Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour Donald Mabbott
NCT05227287 CLARIFY: ADH1 and ADH2 Disease Monitoring Study (DMS) Calcilytix Therapeutics, Inc., a BridgeBio company
NCT05225857 A First-in-Human Study Evaluating AGA2118 in Men and Postmenopausal Women Angitia Biopharmaceuticals
NCT05220293 Treatment of Eosinophilic Chronic Rhinosinusitis Utilizing Betamethasone Dipropionate Nasal Cream Oticara Australia PTY LTD
NCT05213624 A Study to Test BI 764198 in People With a Type of Kidney Disease Called Primary Focal Segmental Glomerulosclerosis Boehringer Ingelheim
NCT05208944 THIO Sequenced With Cemiplimab in Advanced NSCLC Maia Biotechnology
NCT05202379 CC-42344 Safety Study in Healthy Participants Cocrystal Pharma, Inc.
NCT05200624 Subthreshold Laser Treatment in Intermediate Age-related Macular Degeneration With Nascent Geographic Atrophy Study Center for Eye Research Australia
NCT05199753 Study of LM-108 as a Single Agent or in Combination With Anti-PD-1 Antibody in Subjects With Advanced Solid Tumours LaNova Australia Pty Limited
NCT05194787 TAS Test: Online Motor-cognitive Tests for Early Detection of Alzheimer's Disease University of Tasmania
NCT05192473 POWER: Pulse Intravascular Lithotripsy (Pulse IVL) to Open Vessels With Calcific Walls and Enhance Vascular Compliance and Remodeling Amplitude Vascular Systems, Inc.
NCT05185583 Methylphenidate in Childhood Apraxia of Speech Murdoch Childrens Research Institute
NCT05183646 A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB Dimerix Bioscience Pty Ltd
NCT05177809 RFC1 Natural History Study Prof. Dr. Matthis Synofzik
NCT05165628 Safety, Tolerability and Efficacy of CYP-006TK in Adults With Diabetic Foot Ulcers Cynata Therapeutics Limited
NCT05150457 Safety and Preliminary Efficacy of BNA035 in Patients With Advanced Solid Tumors Binacea Pharma, Inc.
NCT05135052 Rhenium-Skin Cancer Therapy (SCT) for the Treatment of Non-Melanoma Skin Cancer. OncoBeta Therapeutics
NCT05130970 CSL312 Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis CSL Behring
NCT05114889 Safety and Tolerability of BSI-045B in Healthy Adult Subjects and Patients With Atopic Dermatitis Biosion, Inc.
NCT05109091 Study of ATH434 in Participants With Multiple System Atrophy Alterity Therapeutics
NCT05099432 The CARMA Technique Study Princess Alexandra Hospital, Brisbane, Australia
NCT05086692 A Beta-only IL-2 ImmunoTherapY (ABILITY) Study Medicenna Therapeutics, Inc.
NCT05083364 Study of ARO-C3 in Adult Healthy Volunteers and Patients With Paroxysmal Nocturnal Hemoglobinuria and Complement-Mediated Renal Disease Arrowhead Pharmaceuticals
NCT05081245 ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD) MapLight Therapeutics
NCT05054530 Assessment of the Safety, Tolerability, and Pharmacokinetic of GMA106 Gmax Biopharm Australia Pty Ltd.
NCT05046665 A Single-centre, Open-label, Phase I Study to Evaluate the Diagnostic Performance of 89Zirconium-labelled Girentuximab (89Zr-TLX250) PET in Urothelial Cancer Patients (ZiPUP Study) South Metropolitan Health Service
NCT05041257 Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers (PICCOLO) ImmunoGen, Inc.
NCT05032196 Study of WVE-003 in Patients With Huntington's Disease Wave Life Sciences Ltd.
NCT05030285 Telehealth Psychotherapy for Anxiety in Persons With Cognitive Impairment The University of Queensland
NCT05026632 NPI-002 Intravitreal Implant for the Delay of Cataract Progression Nacuity Pharmaceuticals, Inc.
NCT05025813 Neoadjuvant Pembrolizumab in Cutaneous Squamous Cell Carcinoma Queensland Health
NCT05013099 Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies ImaginAb, Inc.
NCT05012423 FTIH Study of ECC0509 in Healthy Volunteers Eccanga Pty Ltd
NCT05011851 An Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Oral NNZ-2591 in Angelman Syndrome Neuren Pharmaceuticals Limited
NCT05003141 PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies Qilu Puget Sound Biotherapeutics (dba Sound Biologics)
NCT04994912 First in Human Study of EI-001 Monoclonal Antibody in Healthy Volunteers Elixiron Immunotherapeutics Inc.
NCT04993079 Clotild® Smart Guidewire System (CSGS) Evaluation in EndovascUlar Thrombectomy Procedure Sensome
NCT04982094 Counting On U: Towards Better Mental Health Leanne Saxon
NCT04977063 Atmo SmartPill Comparison in Gastroparetic and Slow Transit Constipation Patients Atmo Biosciences Pty Ltd
NCT04973137 A Study to Evaluate the Efficacy and Safety of Birtamimab in Mayo Stage IV Patients With AL Amyloidosis Prothena Biosciences Ltd.
NCT04968574 A Study Evaluating the Safety and Efficacy of ENV-101 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) Endeavor Biomedicines, Inc.
NCT04963140 Self-Management Of Asthma By Forced Oscillation Technique Restech Srl
NCT04923256 AAT-APP+: A Novel Brain-training App to Reduce Drinking Turning Point
NCT04919499 A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment Boehringer Ingelheim
NCT04912856 An Open-Label Extension of the Study XEN496 (Ezogabine) in Children With KCNQ2-DEE Xenon Pharmaceuticals Inc.
NCT04901806 Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors Pyramid Biosciences
NCT04901078 A Phase 1 Study Investigating the Safety, Tolerability and Pharmacokinetics of KNX100 in Healthy Volunteers Kinoxis Therapeutics Pty Ltd
NCT04898426 Effect of Enhanced Interactive Text Messages and Phone Instruction on the Quality of Bowel Preparation for Colonoscopy. Griffith Base Hospital
NCT04898348 A Study to Investigate Efficacy and Safety of KBL697 in Patients With Mild to Moderate Active Ulcerative Colitis KoBioLabs
NCT04894240 A Study of Monepantel in Individuals With Motor Neurone Disease PharmAust Ltd
NCT04878510 Non-invasive Ventilation and Dex in Critically Ill Adults St. Joseph's Healthcare Hamilton
NCT04875975 A Study to Test the Efficacy, Safety, and Pharmacokinetics of Rozanolixizumab in Adult Study Participants With Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis UCB Biopharma SRL
NCT04875754 A Study Evaluating the Safety, Tolerability, and Range of Biologically Active Doses of ICM-203 in Mild to Moderate Knee Osteoarthritis ICM Biotech Australia Pty Ltd.
NCT04867057 Trichomylin® Safety, Tolerability, and Pharmacokinetics in Healthy Adults and First in Human Osteoarthritis Pain Evaluation ZYUS Life Sciences Inc.
NCT04840784 First-in Human (FIH) Trial of ETH-155008 in Subjects With B-NHL, CLL/SLL and AML Shengke Pharmaceuticals Pty Ltd
NCT04835805 A Study to Evaluate the Safety and Activity of Belvarafenib as a Single Agent and in Combination With Either Cobimetinib or Cobimetinib Plus Atezolizumab in Patients With NRAS-mutant Advanced Melanoma. Genentech, Inc.
NCT04816604 Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH) GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.
NCT04801095 A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors Wellmarker Bio
NCT04773782 A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling Blueprint Medicines Corporation
NCT04764448 A Study of Belcesiran in Patients With AATLD Dicerna Pharmaceuticals, Inc.
NCT04748510 Functionally Aligned vs Mechanical Axis Aligned Total Knee Arthroplasty Perth Hip and Knee
NCT04746612 First in Human Study to Evaluate the Safety, Tolerability of HH30134 in Advanced Solid Tumors Haihe Biopharma Co., Ltd.
NCT04735575 A Ph1/2 Study of EMB-06 in Participants With Relapsed or Refractory Myeloma Shanghai EpimAb Biotherapeutics Co., Ltd.
NCT04721756 Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging Avid Radiopharmaceuticals
NCT04713891 A Study of KF-0210 in Advanced Solid Tumors Patients Keythera Pharmaceuticals (Australia) Pty Ltd
NCT04701281 Study of Intra-Arterial Oxaliplatin Plus Capecitabine to Treat Liver Metastases From Colorectal Cancer AllVascular
NCT04676711 A Study of GFH312 in Healthy Subjects GenFleet Therapeutics (Australia) Pty Ltd.
NCT04665206 Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors Enriched for Tumors With NF2 Gene Mutations Vivace Therapeutics, Inc
NCT04658537 Advanced Techniques for Single-fraction Palliative Radiotherapy Versus ASPIRE-single Royal North Shore Hospital
NCT04618393 A Study of EMB-02 in Participants With Advanced Solid Tumors Shanghai EpimAb Biotherapeutics Co., Ltd.
NCT04613921 Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs European Foundation for Study of Chronic Liver Failure
NCT04611555 ICF in Cochlear Implant Users University Hospital, Antwerp
NCT04602858 The SafeTrip Study - Step Training to Reduce Falls in Older Adults Neuroscience Research Australia
NCT04590001 Effect of the MobiusHD® in Patients With Heart Failure Vascular Dynamics, Inc.
NCT04585100 FM101 Safety, Tolerability, Efficacy Study in the Patients With Ocular Hypertension Future Medicine
NCT04581512 Study to Evaluate the Safety and Tolerability of EP0042 Ellipses Pharma
NCT04563026 A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment Durect
NCT04544410 A Ph2b to Evaluate Tildacerfont in the Reduction of Glucocorticoid Steroid Doses in Adult CAH Spruce Biosciences
NCT04544293 Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Savara Inc.
NCT04525794 BRight DCB First-in-Human Study Biotronik CRC Inc.
NCT04519645 A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures UCB Biopharma SRL
NCT04500587 Phase 1 First in Human Study of ZN-d5 as a Single Agent K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.
NCT04455932 HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Suboptimal Ultrasound Visualisation Concord Repatriation General Hospital
NCT04450732 Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors GeneQuantum Healthcare (Suzhou) Co., Ltd.
NCT04437368 EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005 Gyroscope Therapeutics Limited
NCT04416516 Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor Ascend Biopharmaceuticals Ltd
NCT04355689 Safety and Efficacy of NPI-001 Tablets for RP Associated With Usher Syndrome Nacuity Pharmaceuticals, Inc.
NCT04322136 AMPLE-3: IPC Plus Talc vs VATS in Management of Malignant Pleural Effusion The University of Western Australia
NCT04290299 Endometrial Cancer Conservative Treatment (E.C.Co). A Multicentre Archive National Cancer Institute, Naples
NCT04253301 Feasibility of the InnoVein Valve and Delivery System for Chronic Venous Insufficiency InnoVein